Partners
Boehringer Ingelheim and sanofi-aventis have provided a financial grant towards this independent Programme.
We believe that we share one fundamental principle with the NHS: we both put patients at the heart of what we do.
Our shared belief in putting patients first is a simple principle that should inspire us to develop true and meaningful partnerships that improve the health and quality of patients’ lives.
As a family owned company we are able to take a long term view. We understand that relationships take time to build with trust and reliability being an important foundation to any working relationship.
For 125 years we have consistently developed innovative medicines that have improved the lives of patients in areas of high unmet clinical need such as: respiratory, cardiovascular and central nervous system diseases. In addition, we have successfully advanced our research in stroke prevention, diabetes and cancer (oncology).
Recent evidence of our commitment to partnership can be seen through our proactive work with several NHS and patient organisations, aimed at raising awareness of preventable thromboembolic disease.
We can help develop bespoke solutions for NHS organisations to meet local and national priorities. We also have a skilled and experienced in-house team that can help develop value-added services to improve patient care. We are a natural fit for the NHS and ideal partners for people who are passionate about improving lives.
If you would like to know more about how we can help you to deliver world-class patient care, then please contact us. We look forward to exploring opportunities to work with you.
Drew Owenson
Country
Managing Director
Boehringer Ingelheim
PartnershipWorking.bra@boehringer-ingelheim.com
In the UK, sanofi-aventis, an affiliate of the global pharmaceutical company sanofi-aventis, is a healthcare organisation working to meet the needs of healthcare professionals and their patients. Our portfolio of products and services closely match the priorities of the NHS and include diabetes, cardiovascular disease, thrombosis, oncology and vaccines.
sanofi-aventis is based in Paris operates in over 100 countries. The UK head office is in Guildford, Surrey.
sanofi-aventis, as a Low Molecular Weight Heparin manufacturer, has 19 years experience of preventing and treating thrombosis in the UK. Sanofi-aventis UK have supported both Anticoagulation Europe and Lifeblood to raise awareness about the risks and management of venous thromboembolism (VTE) and are also a co-sponsor of the All-Party Parliamentary Thrombosis Group.